Stocks
ResMed (RMD) EBITDA US GAAP (year values) |
|||||||||
| 2023 | 2023 | 2024 | 2024 | 2025 | LTM ? | CAGR 5 years ? | |||
| EBITDA, bln rub | ? | 1 340 | 1 359 | 1 693 | 1 534 | 1 913 | 2 102 | ||
| Changes by years, y/y, % | +14% | +1% | +25% | -9% | +25% | +14.1% | |||
ResMed. EBITDA US GAAP, bln rub
ResMed. EBITDA US GAAP, changes, %
ResMed. EBITDA US GAAP, sum by quarters, bln rub
ResMed (RMD) EBITDA US GAAP (quarter values) |
||||||||
| 2025Q3 | 2025Q4 | 2026Q1 | 2026Q2 | 2026Q3 | LTM ? | |||
| EBITDA, bln rub | ? | 469.6 | 532.3 | 503.3 | 566.4 | 499.8 | 2 102 | |
| Changes by years, y/y, % | +9% | +47% | +14% | +18% | +6% | |||
| Changes by quarters, q/q, % | -2% | +13% | -5% | +13% | -12% | |||
